Official recall notice

FDA DrugClass IINotable

FDA Recall: Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000

Recall date
2026-07-08
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.

Product description

CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.

Affected products

Lot 3244413; Exp. 12/31/2028

Related Recalls